Industry Day for FDA Contact Center Optimization
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Food and Drug Administration (FDA) hosted an Industry Day on March 5, 2026, for its Contact Center Optimization Project. This special notice provides consolidated meeting minutes and presentation slides, outlining the FDA's vision to modernize its enterprise-wide customer engagement infrastructure. The future opportunity will involve implementing a comprehensive, tiered contact center solution integrated with an enterprise Customer Relationship Management (CRM) system. A solicitation is targeted for release within 60-90 days (FY26).
Project Vision & Scope
The FDA aims to create a unified, intelligent "front door" for agency inquiries, moving from fragmented systems to a tiered structure (Tier 0-3) and an enterprise CRM platform. The project involves defining, designing, developing, implementing, configuring, integrating, training, operating, and maintaining a unified Contact Center Optimization (CCO) solution. This solution will establish an enterprise-wide contact center capability across all FDA centers, offices, and programs, serving as a single point of entry for inquiries and complaints. Key components include a three-tier service model (Self-Service/Automated, Consolidated Intake/Triage, AI-assisted classification/routing) and an enterprise CRM for a 360-degree view of customer interactions.
Contract Details & Timeline
The desired period of performance for the future contract is five years (August 3, 2026 - August 2, 2031), structured as a base period with four option periods. The proposed contract type is Firm-Fixed-Price. The procurement will follow a Statement of Objectives (SOO) to Performance Work Statement (PWS) approach, with vendors writing the PWS. It will be a full and open competition, with small business participation encouraged. The solicitation is anticipated within 60-90 days (FY26).
Key Takeaways & Evaluation
The Industry Day highlighted the FDA's core goals: implementing a tiered contact center structure and enterprise CRM, forming a Business Advisory Group, and establishing CRM governance. The FDA seeks best-of-breed solutions, planning to integrate existing systems (Genesis, Salesforce, Appian, ServiceNow) with AI capabilities and a unified analytics platform. Change management will be a significant evaluation factor, as vendors will serve a dual role as consultant and solution provider. Contractor personnel will require security clearances and FDA training.
Additional Information
The place of performance will include FDA facilities (White Oak Campus, Silver Spring, MD) and contractor facilities. Interested parties should monitor SAM.gov for future announcements and the release of the solicitation.